CDT Equity Inc.
CDT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001896212
In the last 90 days, CDT Equity Inc. insiders filed 0 open-market purchases and 1 sale; 8 institutions reported holding it in 13F filings for Q2 2026, worth $94.7K in total; no superinvestor holds it.
Other share classesCDTTW
Q3 2023 vs. Q2 2023
How the institutions holding CDT Equity Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 0 | 3 | +3 |
| Shares | 0 | 5.35K | +5.35K |
| Value | $0 | $32.0K | +$32.0K |
New holders (3)
Institutions that held CDT Equity Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Group AG | 3,828 | $22.9K | 0.00% |
| Kepos Capital LP | 1,500 | $9.00K | 0.00% |
| Morgan Stanley | 25 | $149 | 0.00% |
Sold out (0)
Institutions that held CDT Equity Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
None.